Since 1985, we have reversed the impact of these adverse effects and increased revenue and profit for almost two thousand client pharmacies across the country by:

• Restructuring of prescription pricing algorithms to increase revenue and profit and maximize third party reimbursements.
• Analysis of third party adjudications to set pricing levels that optimize payments on submissions.
• PBM cost “watch lists” for cost increases likely to be under-reimbursed and guidelines to resubmit for correction.
• Strategies for issues that impact pharmacy profits including PBM “claw backs”, escrows, formulary changes and the effects of high copays and deductibles.